INSERT INTO sites(host) VALUES('pfizer.com') 1045: Access denied for user 'www-data'@'localhost' (using password: NO) pfizer.com Estimated Worth $29,183 - MYIP.NET Website Information
Welcome to MyIP.net!
 Set MYIP as homepage      

  
           

Web Page Information

Title:
Meta Description:
Meta Keywords:
sponsored links:
Links:
Images:
Age:
sponsored links:

Traffic and Estimation

Traffic:
Estimation:

Website Ranks

Alexa Rank:
Google Page Rank:
Sogou Rank:
Baidu Cache:

Search Engine Indexed

Search EngineIndexedLinks
 Google:
 Bing:
 Yahoo!:
 Baidu:
 Sogou:
 Youdao:
 Soso:

Server Data

Web Server:
IP address:    
Location:

Registry information

Registrant:
Email:
ICANN Registrar:
Created:
Updated:
Expires:
Status:
Name Server:
Whois Server:

Alexa Rank and trends

Traffic: Today One Week Avg. Three Mon. Avg.
Rank:
PV:
Unique IP:

More ranks in the world

Users from these countries/regions

Where people go on this site

Alexa Charts

Alexa Reach and Rank

Whois data

Who is pfizer.com at whois.markmonitor.com

Domain Name: pfizer.com

Registry Domain ID: 3979630_DOMAIN_COM-VRSN

Registrar WHOIS Server: whois.markmonitor.com

Registrar URL: http://www.markmonitor.com

Updated Date: 2017-04-10T12:23:16-0700

Creation Date: 1992-04-27T21:00:00-0700

Registrar Registration Expiration Date: 2021-04-28T21:00:00-0700

Registrar: MarkMonitor, Inc.

Registrar IANA ID: 292

Registrar Abuse Contact Email: abusecomplaints

Registrar Abuse Contact Phone: +1.2083895740

Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)

Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)

Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)

Registry Registrant ID:

Registrant Name: Domain Registrations

Registrant Organization: Pfizer Inc. (NYHQ)

Registrant Street: 235 E. 42nd St ,

Registrant City: New York

Registrant State/Province: NY

Registrant Postal Code: 10017-5755

Registrant Country: US

Registrant Phone: +1.2127332323

Registrant Phone Ext:

Registrant Fax: +1.2125732273

Registrant Fax Ext:

Registrant Email: domainregistrations@pfizer.com

Registry Admin ID:

Admin Name: Domain Registrations

Admin Organization: Pfizer Inc. (NYHQ)

Admin Street: 235 E. 42nd St ,

Admin City: New York

Admin State/Province: NY

Admin Postal Code: 10017-5755

Admin Country: US

Admin Phone: +1.2127332323

Admin Phone Ext:

Admin Fax: +1.2125732273

Admin Fax Ext:

Admin Email: domainregistrations@pfizer.com

Registry Tech ID:

Tech Name: Domain Registrations

Tech Organization: Pfizer Inc. (NYHQ)

Tech Street: 235 E. 42nd St ,

Tech City: New York

Tech State/Province: NY

Tech Postal Code: 10017-5755

Tech Country: US

Tech Phone: +1.2127332323

Tech Phone Ext:

Tech Fax: +1.2125732273

Tech Fax Ext:

Tech Email: domainregistrations@pfizer.com

Name Server: ns4.p15.dynect.net

Name Server: ns3.p15.dynect.net

Name Server: ns2.p15.dynect.net

Name Server: ns1.p15.dynect.net

DNSSEC: unsigned

URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/

>>> Last update of WHOIS database: 2017-04-23T18:42:50-0700 <<<



The Data in MarkMonitor.com's WHOIS database is provided by MarkMonitor.com for

information purposes, and to assist persons in obtaining information about or

related to a domain name registration record. MarkMonitor.com does not guarantee

its accuracy. By submitting a WHOIS query, you agree that you will use this Data

only for lawful purposes and that, under no circumstances will you use this Data to:

(1) allow, enable, or otherwise support the transmission of mass unsolicited,

commercial advertising or solicitations via e-mail (spam); or

(2) enable high volume, automated, electronic processes that apply to

MarkMonitor.com (or its systems).

MarkMonitor.com reserves the right to modify these terms at any time.

By submitting this query, you agree to abide by this policy.



MarkMonitor is the Global Leader in Online Brand Protection.



MarkMonitor Domain Management(TM)

MarkMonitor Brand Protection(TM)

MarkMonitor AntiPiracy(TM)

MarkMonitor AntiFraud(TM)

Professional and Managed Services



Visit MarkMonitor at http://www.markmonitor.com

Contact us at +1.8007459229

In Europe, at +44.02032062220



For more information on Whois status codes, please visit

https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en

Front Page Thumbnail

sponsored links:

Front Page Loading Time

Keyword Hits (Biger,better)

Other TLDs of pfizer

TLDs Created Expires Registered
.com
.net
.org
.cn
.com.cn
.asia
.mobi

Similar Websites

More...
Alexa鏍囬

Search Engine Spider Emulation

Title:Pfizer: One of the world's premier biopharmaceutical companies
Description:
Keywords:
Body:
Pfizer: One of the world's premier biopharmaceutical companies
Skip to main content
top menu
En
Argentina
Australia
Austria
Belgium
Brazil
Canada
China
Colombia
Czech Republic
Denmark
Finland
France
Germany
Greece
Hong Kong
Hungary
India
Indonesia
Ireland
Israel
Italy
Japan
Korea
Malaysia/Singapore
Mexico
Netherlands
New Zealand
Norway
Pakistan
Philippines
Poland
Portugal
Romania
Russia
Slovakia
South Africa
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
United Kingdom
Ukraine
Audience navigation
Health ProfessionalsCareersPartnersPartnership HighlightsContactsBusiness Developments LeadersEvents Pfizer is AttendingSubmit Your OpportunitiesAreas of InterestBiopharmaceuticalsConsumer HealthcareCore Therapeutic AreasInnovationResearch amp; DevelopmentClinical InnovationGene TherapyVenture InvestmentsContact UsFrequently Asked QuestionsPrivacy Policy
About Us
About Us禄
Discover who we are and what we stand for.
Meet Pfizer.
Leadership and StructureMeet Our Executives
Meet the Pfizer Board of Directors
Company Fact Sheet
Ethics and ComplianceCorporate Compliance
Code of Conduct
Sales and Marketing Compliance
Our MissionOur Journey
Accolades
How does Pfizer price medicines?
Policy Positions
Value of Medicines
Corporate GovernanceBoard Committees and Charters
Pfizer Board Policies
Corporate Governance FAQs
Contact Our Directors
Diversity and Inclusion
Products
Products禄
Learn more about our products, viewing information intended for residents of the United States.
View our product list.
DistributorsPfizer Distributors
Greenstone Distributors
Resource Center
Medical Information
Material Safety Data Sheets
Counterfeiting
Research
Research禄
R amp;D is at the heart of fulfilling Pfizer's purpose as we work to translate advanced science and technologies into the therapies that matter most.
See where we're going.
Therapeutic Areas Immunology amp; Inflammation
CV amp; Metabolic Diseases
Oncology
Vaccines
Neuroscience amp; Pain
Rare Disease
Clinical TrialsWhat Are Clinical Trials?
How We Conduct Trials
Clinical Innovation
Trial Data amp; Results
Find a Trial
Post Marketing Commitments
R amp;D PartneringWorking in R amp;D
R amp;D Ecosystem
Centers for Therapeutic Innovation
Investigator-Initiated Research
Compound Transfer Program
Careers
Post-doc Program
Partnering
Compassionate Use and Expanded Access
Science amp; TechnologyR amp;D Vision
Meet Our Scientists
Product Pipeline
Operating Model
R amp;D Platforms
Biosimilars
R amp;D Locations
Responsibility
Responsibility禄
Ready for Cures
Individual Voices
Building Healthcare CapacityGlobal Health Grants and Investments
Global Health Fellows
Expanding Access to MedicinesInternational Trachoma Initiative
Diflucan Partnership Program
Pfizer Rx Pathways
Relief amp; Emergency Humanitarian Assistance
Corporate Citizenship
Global Institutions and Partnerships
Reporting Trends and Progress
Protecting the EnvironmentEHS in our Supply Chain
EHS Governance
Key Performance Indicators
Pfizer #039;s Green Journey
Product Stewardship
Workplace ResponsibilityHIV/AIDS Workplace Policy
Pfizer Health and Safety
Human Rights Statement
TransparencyWorking With Health Care Professionals
Grants and ContributionsTransparency in Grants
Lobbying amp; Political Contributions
Independent Grants for Learning amp; Change
Medical amp; Academic Partnerships
Health Care Charitables
Special Events
Device Challenge
Health
Health禄
At Pfizer, we believe it is very important for people to take a proactive approach to managing their health.
Take control of your health.
Medicine SafetyMedicine Safety Education
Medicine Safety At Pfizer
Reporting Adverse Events
Patient Assistance ProgramsGovernment Programs
VaccinesLegacy of Achievement
In the Developing World
Meet Our Vaccines Leaders
Senior HealthMedicare Resources
Taking Your Medications Correctly
Vitamins amp; Your Health
GetHealthy StayHealthy.com
BiosimilarsBiologics amp; Biosimilars
Pfizer Heritage
Anatomy of a Market Leader
Caregiving
Health LiteracyPatients and Families
Healthcare Professionals
Public Policy/Researchers
Rare DiseaseRare Disease Home
鈥婣dvocacy
Areas of Focus
Pipeline and Clinical Trials
Research
Grants and Contributions
Business Partnering Opportunities
Our Rare Disease Leaders
Investors
Investors禄
Become an informed investor: learn more about investing in Pfizer.
See what tools we have to offer.
Shareholder ServicesStock FAQs
Advisory Information
Investor Dashboard
Cost Basis Calculator
Hospira Transaction
SEC filingsInteractive Data Filings (XBRL)
Presentations
Financial Reports
CEO/CFO Certifications
Prospective Investors
Hospira Exchange Offer Tax Information
News
News禄
Find information and resources for journalists, including releases, statements and press kits.
Get the latest.
Press ReleasesPress Release Archive
Press Statements
Press Kits amp; DownloadsCompany Press Kit
Vaccines Press Kit
Get Old Press Kit
Breast Cancer: A Story Half Told
Pfizer Oncology Press Kit
RA NarRAtive
TTR Amyloidosis Press Kit
Features
Frequently Requested Info
Social Media
Video Gallery
Contact Media Relations
Featured Stories
Pfizer is Proud to Join Access Accelerated
Featured Stories
Applying science to discover therapies that significantly improve and extend people's lives. Learn more about us 禄
Milestone: 250M Pneumococcal Conjugate Vaccine... 禄
Scaling Up Breast Cancer Care Capabilities around... 禄
Pfizer Earns Perfect Score on LGBT Ranking
Meeting the Challenges of Metastatic Breast Cancer... 禄
Find a product
A-Z List of products 禄
Over-the-counter products 禄
Prescription products 禄
Patient assistance programs 禄
Pfizer on:
Facebook
Twitter
Youtube
Slideshare
Linkedin
Social Media
For Investors 禄
Pfizer Quarterly Corporate Performance 鈥 Fourth Quarter 2016
Audio Webcast
- Tuesday, January 31, 2017 - 10:00 AM E.S.T.
Performance Report
- Fourth Quarter 2016
Q4 2016 PFE Product Revenues (Includes Historicals)
- XLSX
Recast 2016 Quarterly Income Statements -- ASU 2016-09
- XLSX
Presentation
- PDF
Transcript
- PDF
35th Annual J.P. Morgan Healthcare Conference
Audio Webcast
- Tuesday, January 10, 2017 - 10:30 AM P.S.T.
Transcript
- PDF
.
.
.
Stock Quote at: .
Change
.
Vol
.
Day High
.
52 Wk. High
.
Day Low
.
52 Wk. Low
.
Open
.
Mkt. Cap(Bil)
.
Prev Close
.
Stock Symbol:
.
Stock Exchange:
.
More Information for Investors
Press Releases
Relationship Expert Teams Up with Pfizer to Address Intimacy and...
PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2016 RESULTS
Pfizer Receives Positive CHMP Opinion in Europe for XELJANZ庐 (...
View all Press Releases 禄
RSSTwitter
聽
Career-seekers
Investors
News amp; Media
Health Professionals
Partners
Business to Business
Change Country
Contact Us
Sitemap
Terms of Use
Privacy Policy
聽
Copyright copy; 2002 ndash;2017 Pfizer Inc. All rights reserved. This information - including product information - is intended only for residents of the United States. The products discussed herein may have different labeling in different countries.

Updated Time

Updating   
Friend links: ProxyFire    More...
Site Map 1 2 3 4 5 6 7 8 9 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 250 300 350 400 450 500 550 600 610 620 630 640 650 660 670 680 690 700 710 720 730 740 750
TOS | Contact us
© 2009 MyIP.cn Dev by MYIP Elapsed:1.488ms